Skeletal Fragility in Type 1 Diabetes: Glycemic Control and Bone Strength

Description

The purpose of this research study is to find out how bones are affected in children and adolescents with type 1 diabetes (T1D) as compared to children and adolescents without type 1 diabetes.

Conditions

Type1diabetes

Talk to us

Study Overview

On this page

Study Details

Study overview

The purpose of this research study is to find out how bones are affected in children and adolescents with type 1 diabetes (T1D) as compared to children and adolescents without type 1 diabetes.

Skeletal Fragility in Type 1 Diabetes: Glycemic Control and Bone Strength

Skeletal Fragility in Type 1 Diabetes: Glycemic Control and Bone Strength

Condition
Type1diabetes
Intervention / Treatment

-

Contacts and Locations

New York

Columbia University Medical Center-Harkness Pavillion, New York, New York, United States, 10032

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Estimated glomerular filtration rate (eGFR)\< 60 ml/mim
  • * 25(OH)D level \< 20 ng/ml.
  • * Celiac disease
  • * Autoimmune thyroid disease
  • * Addison's disease
  • * History of pathological fractures
  • * Bone active drugs in past year
  • * Diabetes of other or unclear etiology

Ages Eligible for Study

8 Years to 14 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

Columbia University,

Mishaela Rubin, MD, PRINCIPAL_INVESTIGATOR, Columbia University

Study Record Dates

2024-12-01